Eli Lilly's phase 2 study of Mounjaro and Zepbound found promising results for the medications to treat fatty liver disease, the drugmaker said Feb. 6. 

Respiratory syncytial virus vaccinations could soon extend to adults aged 50-59. 

In 2024, the cost of Ozempic increased 3.5% as health systems, payers and patients scramble to manage the drug's soaring popularity. 

Eli Lilly's ingredient for Type 2 diabetes medication Mounjaro and its new weight loss drug, Zepbound, significantly lowered patients' blood pressure by up to 10.6 mmHg, according to a new study published Feb. 5. 

Walgreens has formed a new advisory council with pharmacy school leaders to address staffing challenges and fortify the pipeline of future pharmacists.

As Novo Nordisk increases the output of its popular weight loss drug Wegovy, the Denmark-based drugmaker agreed to buy three fill-finish manufacturing sites for $11 billion. 

Yale New Haven (Conn.) Health is opening its fourth pharmacy Feb. 6, which will offer home deliveries, according to a news release shared with Becker's. 

In October, NYC Health + Hospitals became the first public health system in the U.S. to launch telehealth abortion access, which includes medication abortion for eligible patients. 

Flexibilities for the opioid use disorder treatment methadone made during the COVID-19 pandemic have now been made permanent, HHS said Feb. 1, marking the first substantial changes to its regulations in 20 years. 

Multiple solutions of etoposide and topotecan are on back order.